Read the latest press releases for 4D pharma plc.
Click on a news title to read full details. For Regulatory News Service (RNS) announcements please click here.
4 Jun 2021, 07:00
4D pharma completes target enrollment of 30 patients for Part A of its Phase I/II clinical trial of…
24 May 2021, 07:00
New data demonstrating clinical activity of Live Biotherapeutic Blautix in both IBS-C and IBS-D was…
17 May 2021, 07:00
4D pharma to Present Additional Data from its completed Phase II Study of Blautix for the Treatment…
19 Apr 2021, 07:00
4D pharma announces a collaboration with Parkinson’s UK, a non-profit organization focused on…
15 Apr 2021, 07:00
4D pharma CEO, Duncan Peyton, and CSO, Alex Stevenson, will participate in a fireside chat at the…
7 Apr 2021, 07:00
This announcement is intended to guide holders of Ordinary Shares, which are admitted to trading on…
1 Apr 2021, 07:00
4D pharma plc (AIM: DDDD, NASDAQ: LBPS), a pharmaceutical company leading the development of Live…
22 Mar 2021, 07:00
4D pharma's business combination with Longevity Acquisition Corporation has now become effective,…
18 Mar 2021, 13:30
4D pharma and Longevity Acquisition Corporation receive shareholder approval to complete business…
17 Mar 2021, 13:00
Company expects to complete merger with Longevity Acquisition Corporation and its American…
3 Mar 2021, 07:00
4D pharma management will present and meet with investors at three upcoming investor conferences…
1 Mar 2021, 07:00
4D pharma announces the appointment of Paul Maier as Non-Executive Director of the Board. Mr Maier…
1 Mar 2021, 07:00
4D pharma announces the appointment of John Beck as Chief Financial Officer (CFO) and member of the…
26 Feb 2021, 07:00
4D pharma to list ADSs on NASDAQ in conjunction with the merger agreement between 4D pharma and…
16 Feb 2021, 07:00
Duncan Peyton, Chief Executive Officer of 4D pharma, will participate in Cantor Fitzgerald's virtual…
